The Royal Palace of Norway has confirmed that Crown Princess Mette-Marit, 51, has been placed on the national lung transplant waiting list due to a progressive lung condition. The princess, who has been diagnosed with idiopathic pulmonary fibrosis, a chronic scarring of the lungs that impairs oxygen uptake, will now await a suitable donor organ. The condition, which often leads to breathlessness and fatigue, has required her to reduce public engagements in recent years.
The palace stated that the decision was made following medical evaluations at the Oslo University Hospital and that the princess remains in stable condition. Lung transplants carry a five-year survival rate of approximately 55% for patients with pulmonary fibrosis, according to the International Society for Heart and Lung Transplantation. The princess's medical team will administer immunosuppressive therapy post-surgery to prevent organ rejection.
The palace has requested privacy for the royal family during this time. The announcement comes amid a broader discussion on organ donation in Norway, where consent is presumed unless individuals opt out. The Norwegian Directorate of Health reports that over 600 patients are currently on waiting lists for various organs, with lungs having the longest median wait time of 18 months.
The crown princess's condition highlights the fragility of human biology even for those in positions of privilege. No date for the transplant has been set.
